A.V. Wallace

1.2k citations

20 papers · 706 indexed · h-index 15

Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology 3
Physiology top 5%
- Nitric Oxide and Endothelin Effects 8
- Adenosine and Purinergic Signaling 4
Toxicology top 10%
Physiology top 10%
- Nitric Oxide and Endothelin Effects 8
- Adenosine and Purinergic Signaling 4
Biophysics top 10%
Inorganic Chemistry
- Metal-Catalyzed Oxygenation Mechanisms 4
Molecular Biology
- Phosphodiesterase function and regulation 4
- Lipid Membrane Structure and Behavior 2
Surgery
- Pancreatic function and diabetes 3
Nutrition and Dietetics
- Infant Nutrition and Health 2

Co-authors: Miles D. Houslay Alan C. Tinker C M Heyworth Peter Hamley Haydn G. Beaton David Nicholls Sally Wilson John Unitt
Cited by: Biochemistry Physiology Toxicology
Journals: Biochemical Journal (6 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Journal of Medicinal Chemistry (2 papers)
Partner nations: United Kingdom United States Sweden

In The Last Decade

A.V. Wallace

20 papers receiving 669 citations

Peers

Replace R. Keith Webber with:

R. Keith Webber United States

María Benlloch Spain

Giuseppina Morini Italy

David G. Ahern United States

Jill M. McFadden United States

Emanuela Lafavia Italy

José A. Pellicer Spain

Ramakrishna Seethala United States

James S. Frazee United States

Otto Walaas Norway

A.V. Wallace relative to R. Keith Webber United States R. Keith Webber's profile →

Citations per field

00.5×2×3.4×

R. Keith Webber · 1×

×0.4 85/200

BIOCH

×3.4 51/15

PHYSI

×1.1 30/28

TOXIC

×0.4 198/524

PHYSI

×0.4 34/92

BIOPH

Citations per year

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

Countries citing papers authored by A.V. Wallace

Since Specialization

Citations

This map shows the geographic impact of A.V. Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.V. Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.V. Wallace more than expected).

Fields of papers citing papers by A.V. Wallace

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.V. Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.V. Wallace. The network helps show where A.V. Wallace may publish in the future.

Co-authorship network

The 25 scholars most cited alongside A.V. Wallace, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A.V. Wallace Line = papers co-authored together A.V. Wallace links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Nitric Oxide Synthase Inhibitors into the Clinic at Last Handbook of experimental pharmacology ·Vu Thao-Vi Dao,Mahmoud H. Elbatreek,Thomas Fuchß,Ulrich Grädler,Harald Schmidt,Ajay M. Shah,A.V. Wallace,Richard Knowles	2020	17
2	Identification of iNOS Inhibitors Using InteraX™ SLAS DISCOVERY ·Philip R. Mallinder,A.V. Wallace,Gary Allenby	2009	3
3	Selective Inhibitors of Inducible Nitric Oxide Synthase: Potential Agents for the Treatment of Inflammatory Diseases? Current Topics in Medicinal Chemistry ·Alan C. Tinker,A.V. Wallace	2006	92
4	Hit-to-Lead studies: The discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Andrew Baxter,Anne Cooper,Henri Menjaud,Maheswara Rabbani,John Unitt,A.V. Wallace	2005	44
5	2-Aminopyridines as Highly Selective Inducible Nitric Oxide Synthase Inhibitors. Differential Binding Modes Dependent on Nitrogen Substitution Journal of Medicinal Chemistry ·Stephen Connolly,Anders Åberg,A.S. Arvai,Haydn G. Beaton,David R. Cheshire,Anthony R. Cook,Amanda Platter,David Cox,Peter Hamley,张治强,Noelle Coates,David Nicholls,R.J. Rosenfeld,Stephen A. St-Gallay,John A. Tainer,Alan C. Tinker,A.V. Wallace	2004	37
6	1,2-Dihydro-4-quinazolinamines: Potent, Highly Selective Inhibitors of Inducible Nitric Oxide Synthase Which Show Antiinflammatory Activity in Vivo Journal of Medicinal Chemistry ·Alan C. Tinker,Haydn G. Beaton,N. K. Boughton-Smith,Lawrence M. Hoepp,Amanda Platter,Magdalena Welman,Starr Montalvo,Peter Hamley,Tom McInally,David Nicholls,Mohamed Alsumairi,A.V. Wallace	2003	87
7	Conformational Changes in Nitric Oxide Synthases Induced by Chlorzoxazone and Nitroindazoles: Crystallographic and Computational Analyses of Inhibitor Potency Biochemistry ·R.J. Rosenfeld,Elsa D. Garcin,Koustubh Panda,Gunilla Andersson,Anders Åberg,A.V. Wallace,Garrett M. Morris,Arthur J. Olson,Dennis J. Stuehr,John A. Tainer,Elizabeth D. Getzoff	2002	57
8	3,4-Dihydro-1-isoquinolinamines: A novel class of nitric oxide synthase inhibitors with a range of isoform selectivity and potency Bioorganic & Medicinal Chemistry Letters ·Haydn G. Beaton,Peter Hamley,David Nicholls,Alan C. Tinker,A.V. Wallace	2001	32
9	Thienopyridines: nitric oxide synthase inhibitors with potent In vivo activity Bioorganic & Medicinal Chemistry Letters ·Haydn G. Beaton,N. K. Boughton-Smith,Peter Hamley,Rashiqah Syed,David Nicholls,Alan C. Tinker,A.V. Wallace	2001	20
10	Novel Cobalt Complex Inhibitors of Mitochondrial Calcium Uptake Bioorganic & Medicinal Chemistry ·John Unitt,Kaberia Kioni,A.V. Wallace,Anthony H. Ingall,黄立相,Neha Tekriwal	1999	21
11	Extracellular calcium modulates insulin's action on enzymes controlling cyclic AMP metabolism in intact hepatocytes Biochemical Journal ·M Freeman Janine,A.V. Wallace,Julie Houston,Miles D. Houslay	1993	12
12	Antianxiety properties of the angiotensin II antagonist, DUP 753, in the rat using the elevated plus-maze Neuroreport ·董奕洋 DONG Yiyang,Gene C. Palmer,A.V. Wallace,Richard D. Carr,Magdalena Welman,Catherine Hallam	1992	42
13	Subcellular compartmentation in the synthesis of the milk sugars lactose and ?-2,3-sialyllactose PROTOPLASMA ·F. Laurent,Naveenan Navaratnam,Justin Clump,A.V. Wallace,Simon Ward,Nicholas J. Kuhn	1990	13
14	Incorporation into phospholipid vesicles of pore-like properties from Golgi membranes of lactating-rat mammary gland Biochemical Journal ·A.V. Wallace,Nicholas J. Kuhn	1986	4
15	N 6-(Phenylisopropyl)adenosine prevents glucagon both blocking insulin's activation of the plasma-membrane cyclic AMP phosphodiesterase and uncoupling hormonal stimulation of adenylate cyclase activity in hepatocytes Biochemical Journal ·A.V. Wallace,C M Heyworth,Miles D. Houslay	1984	18
16	An assessment of the ability of insulin-stimulated cyclic AMP phosphodiesterase to decrease hepatocyte intracellular cyclic AMP concentrations Biochemical Journal ·C M Heyworth,A.V. Wallace,Sally Wilson,Miles D. Houslay	1984	32
17	Does insulin exert certain of its actions through a distinct species of guanine nucleotide regulatory protein? Biochemical Society Transactions ·Miles D. Houslay,A.V. Wallace,Efren S. Abustan,Richard A. Tilden,Sally Wilson,Clare M. Heyworth	1984	9
18	Insulin activates the plasma-membrane and dense-vesicle cyclic AMP phosphodiesterase in hepatocytes by distinct routes Biochemical Journal ·Sally Wilson,A.V. Wallace,Miles D. Houslay	1983	15
19	Insulin and glucagon regulate the activation of two distinct membrane-bound cyclic AMP phosphodiesterases in hepatocytes Biochemical Journal ·C M Heyworth,A.V. Wallace,Miles D. Houslay	1983	135
20	The thermodependence of the activity of integral enzymes in liver plasma membranes FEBS Letters ·Anthony D. Whetton,Axel Johannsson,Sally Wilson,A.V. Wallace,Miles D. Houslay	1982	16

About A.V. Wallace

A.V. Wallace is a scholar working on Physiology, Biochemistry, Physiology, Inorganic Chemistry and Behavioral Neuroscience, having authored 20 papers that have together received 706 indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (8 papers), Metal-Catalyzed Oxygenation Mechanisms (4 papers), Adenosine and Purinergic Signaling (4 papers), Phosphodiesterase function and regulation (4 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Pancreatic function and diabetes (3 papers), Lipid Membrane Structure and Behavior (2 papers) and Infant Nutrition and Health (2 papers). The work is most often cited by research in Biochemistry (85 citations), Physiology (51 citations), Toxicology (30 citations), Physiology (198 citations) and Biophysics (34 citations). A.V. Wallace has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Miles D. Houslay, Alan C. Tinker, C M Heyworth, Peter Hamley, Haydn G. Beaton, David Nicholls, Sally Wilson, John Unitt, N. K. Boughton-Smith and R.J. Rosenfeld. Their work appears in journals such as Biochemical Journal, Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, SLAS DISCOVERY and Current Topics in Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact